5,6-Dihydroabiraterone | CAS 219843-75-1 - Request Quote
5,6-Dihydroabiraterone
| SZ CAT No: | SZ-A006086 |
| CAS No | 219843-75-1 |
| Mol.F. | C24H33NO |
| Mol.Wt. | 351.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
5,6-Dihydroabiraterone is chemically (3B) 17-(Pyridine-3-yl)androsta-16- ene-3-ol. 5,6-Dihydroabiraterone is supplied with detailed characterization data compliant with regulatory guideline. 5,6-Dihydroabiraterone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abiraterone Acetate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 219843-75-1
Purchase 219843-75-1
Order 219843-75-1
Enquire 219843-75-1
price of 219843-75-1
219843-75-1 Supplier
219843-75-1 Manufacturer
219843-75-1 Exporter
buy high quality 5,6-Dihydroabiraterone
Purchase 5,6-Dihydroabiraterone
5,6-Dihydroabiraterone suppliers
5,6-Dihydroabiraterone manufacturers
5,6-Dihydroabiraterone price
Order 5,6-Dihydroabiraterone
Enquire 5,6-Dihydroabiraterone
5,6-Dihydroabiraterone cost
5,6-Dihydroabiraterone Supplier
5,6-Dihydroabiraterone Distributor
5,6-Dihydroabiraterone for Method Validation
Abiraterone Acetate Reference Standard
5,6-Dihydroabiraterone for ANDA Filing
5,6-Dihydroabiraterone for Forced Degradation Studies
5,6-Dihydroabiraterone Identification Standards
5,6-Dihydroabiraterone for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.